Abstract
The importance of preoperative histological diagnosis in the assessment of breast
lesions in women is widely established, but in men with breast lesions histological
diagnosis is obtained in a limited number of cases. The aim of this study was to report
our single-center experience in a large series of 131 CNB performed for suspicious
male breast lesions. Our data confirmed that CNB is an effective method in distinguishing
between benign and neoplastic lesions in the male breast, thus validating the few
published data. CNB should be a routine part of the unilateral male breast swelling
diagnostic assessment, being precious tool for the clinicians for surgery planning
or avoidance.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Surgical OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Needle core biopsy for the assessment of unilateral breast masses in men.Breast. 2006; 15: 273-275
- The epidemiology of male breast cancer.Curr Oncol Rep. 2016; 18: 1
- Evaluation of fine-needle aspiration cytology of breast masses in males.Cancer. 2002; 96: 101-104
- Breast masses in males: multi-institutional experience on fine-needle aspiration.Diagn Cytopathol. 2002; 26: 87-91
- Core needle biopsy in male breast lesions.J Clin Pathol. 2003; 56: 863-865
- ACR appropriateness criteria evaluation of the symptomatic male breast.J Am Coll Radiol. 2015; 12: 678-682
Article info
Publication history
Published online: August 13, 2016
Accepted:
July 30,
2016
Identification
Copyright
© 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
